[A2k] WTO TRIPS Council - Brazil, China, India and South Africa request discussion of the Final Report of the UN High-Level Panel on Access to Medicines

Thiru Balasubramaniam thiru at keionline.org
Tue Nov 1 04:43:25 PDT 2016


http://keionline.org/node/2654

--


On Thursday, 27 October 2016, Brazil, China, India and South Africa
submitted a communication (IP/C/W/619
<http://keionline.org/sites/default/files/W619-01.pdf>) to the World Trade
Organization (WTO) requesting the WTO Secretariat to "place a dedicated
agenda item for consideration at the 8-9 November 2016 session of the TRIPS
Council entitled “the United Nations Secretary-General’s High-Level Panel
Report on Access to Medicines.” In the WTO submission, Brazil, China, India
and South Africa enclosed the entire Final Report of the UN
Secretary-General's High-Level Panel on Access to Medicines (UN HLP) as an
attachment. This represents the first formal discussion of the HLP Report
and its recommendations at an international organization - following the
publication of the HLP report on 14 September 2016. As noted in footnote 1
of document IP/C/W/619, the "Report of the UN Secretary-General's
High-Level Panel on Access to Medicines is enclosed as an attachment." The
publication date for the submission of Brazil, China, India and South
Africa is 31 October 2016.

The submission can be found here:
http://keionline.org/sites/default/files/W619-01.pdf

--

IP/C/W/619
31 October 2016
(16-5986)
Page: 1/1

Council for Trade-Related Aspects of Intellectual Property Rights Original:
English

THE UNITED NATIONS SECRETARY-GENERAL'S HIGH-LEVEL PANEL REPORT ON ACCESS TO
MEDICINES

COMMUNICATION FROM BRAZIL, CHINA, INDIA AND SOUTH AFRICA

The following communication, dated 27 October 2016 is circulated at the
request of Brazil, China, India and South Africa.

1. In November of 2015, the United Nations Secretary-General, Mr. Ban
Ki-moon, convened a High-Level Panel (HLP) on Access to Medicines with an
objective “to review and assess proposals and recommend solutions for
remedying the policy incoherence between the justifiable rights of
inventors, international human rights law, trade rules and public health in
the context of health technologies.” On 14 September 2016, the United
Nations Secretary-General’s High-Level Panel on Access to Medicines
released its Final Report.

2. In light of the HLP’s final report, Brazil, China, India and South
Africa requests the Secretariat of the World Trade Organization (WTO) to
place a dedicated agenda item for consideration at the 8-9 November 2016
session of the TRIPS Council entitled “the United Nations
Secretary-General’s High Level Panel Report on Access to Medicines.”

3. This co-sponsors of this communication encourage Members to share their
views on the report of the HLP at the 8-9 November 2016 session of the
TRIPS Council.

[Footnote] 1 The Report of the UN Secretary-General's High-Level Panel on
Access to Medicines is enclosed as an attachment to this document for
information (available in English only).



More information about the A2k mailing list